Company: VCYT
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001384101-25-000110
Chunk: 14

Company: VERACYTE, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 14
---
)— — 10,715 — — 10,715 Stock-based compensation expense (ESPP)— — 270 — — 270 Net loss— — — (980)— (980)Other comprehensive income— — — — 16,682 16,682 Balance at June 30, 202578,599 $79 $1,670,853 $(437,916)$(11,959)$1,221,057 Balance at December 31, 202477,773 $78 $1,655,961 $(443,983)$(36,090)$1,175,966 Issuance of common stock upon exercise of stock options and vesting of restricted stock units742 1 3,133 — — 3,134 Issuance of common stock under employee stock purchase plan (ESPP)84 — 1,647 — — 1,647 Tax portion of vested restricted stock units— — (11,831)— — (11,831)Stock-based compensation expense (employee)— — 21,468 — — 21,468 Stock-based compensation expense (ESPP)— — 475 — — 475 Net income— — — 6,067 — 6,067 Other comprehensive income— — — — 24,131 24,131 Balance at June 30, 202578,599 $79 $1,670,853 $(437,916)$(11,959)$1,221,057 

4

 Common StockAdditionalPaid-inCapitalAccumulated DeficitAccumulated Other Comprehensive LossTotalStockholders'Equity SharesAmountBalance at March 31, 202476,425 $76 $1,617,465 $(469,985)$(28,907)$1,118,649 Issuance of common stock on exercise of stock options and vesting of restricted stock units319 1 1,291 — — 1,292 Tax portion of vested restricted stock units— — (1,303)— — (1,303)Stock-based compensation expense (employee)— — 9,573 — — 9,573 Stock-based compensation expense (ESPP)— — 281 —